MCC Researchers Receive Prostate Cancer Foundation 2017 Challenge Awards
Thursday, October 5, 2017
Two of the 2017 Prostate Cancer Foundation (PCF) Challenge Awards were awarded to teams including Meyer Cancer Center investigators.
- Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation ($1 million): Scott Tagawa, M.D., Neil Bander, M.D., and Shankar Vallabhajosula, Ph.D., will conduct clinical trials to test the efficacy of promising new PSMA-targeted radiation-emitting treatments in advanced prostate cancer.
- Targeting BRN2 in Neuroendocrine Prostate Cancer ($1 million): Amina Zoubeidi, Ph.D., (University of British Columbia) and Himisha Beltran, M.D., (Weill Cornell Medicine) will develop a novel therapy targeting BRN2, a driver of the highly aggressive neuroendocrine subtype of prostate cancer, and will develop biomarkers to identify patients who may benefit from this treatment.